At CLS Holdings, we have developed a "seed to sale" acquisition strategy that involves acquiring cannabis dispensaries, cultivators and producers. CLS stands for "Cannabis Life Sciences," in recognition of our patented proprietary method of extracting various cannabinoids from the marijuana plant and converting them into products with a higher level of quality and consistency. CLS Holdings has recently received a Notice of Allowance from the U.S. Patent Office for its proprietary extraction and conversion methodology.